Production in Australia)

PRODUCTS

OUR PRODUCTS

As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local public health needs.

Here you will find a listing of our products available around the globe.

Influenza

Our broad range influenza vaccines meets the needs of different populations around the world. Our marketed product range varies from country to country, please check and review the relevant product information in your country of residence. 

Consumers should contact their health care professional for further advice.

Afluria® Quadrivalent | Inactivated Quadrivalent Influenza Vaccine (split viron)
Also marketed as Afluria® Quad and Afluria® Tetra in various different markets.
COUNTRIES
Afluria® | Inactivated Influenza Vaccine (split viron)
Also marketed as Enzira®, Fluvax® and Nilgrip® in various different markets.
COUNTRIES
Agrippal® | Influenza Vaccine (surface antigen inactivated)
Also marketed as Begripal®, Fluazur®, Sandovac®, Agriflu®, Chiroflu® in various different markets.
COUNTRIES
Fluad® | Inactivated Influenza Vaccine, Adjuvanted
Also marketed as Chiromas® in Spain.
COUNTRIES
Fluad® Pediatric | Inactivated Influenza Vaccine, Adjuvanted
COUNTRIES
Flucelvax® Quadrivalent | Inactivated Influenza Vaccine

Also marketed as Flucelvax® TETRA▼  in various different markets.

COUNTRIES
Rapivab® | Peramivir Injection
COUNTRIES

The trademarks marked ® are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more

 

globe

In-Licensed Vaccines and Pharmaceuticals

Seqirus markets a range of in-licensed vaccines and pharmaceuticals in Australia and New Zealand to meet local health needs.

Antivenoms and Q fever Vaccine

Seqirus manufactures and distributes a range of uniquely Australian products in the National Interest under contract with the Australian Government.

UK/FLU/0519/0080 August 2019

R&D

We focus on optimising our current technologies while also working on longer-term transformational approaches to influenza protection.

Learn more
Innovation

We are driven to transform influenza protection around the world through the development of innovative influenza vaccine technologies and pandemic response solutions.

Learn more
Contact

Questions or concerns? Find the best way to reach us here.

Learn more